Suvoda Updates Clinical Trial Platform With AI and Unified Access
Suvoda LLC announced in a press release an updated clinical trial platform that combines AI tools, shared data and access to eight products through one login. The Product Launchpad connects RTSM and IRT, eCOA, electronic consent, scheduling, patient payments, travel, site payments, and budgeting and benchmarking.
Suvoda said its agentic RTSM capability has reduced the time from project kickoff to user acceptance testing by up to 80%. Its Sofia assistant lets authorized sponsors and trial sites find information and take permitted actions in multiple languages, while logging each action for auditing and retaining human approval.
A shared data layer transfers participant information between products without repeated entry. The platform also adds finance and travel reporting, digital patient payments, appointment scheduling, questionnaires, ride booking and video calls for remote visits.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 30 Xtalks Plans Webinar on AI Governance in Clinical Development Sep 30 Medical Image Analysis Software Market Forecast to Reach $6.3 Billion by 2031 Sep 30 Netwrix Finds Identity Governance Gaps at 79% of Healthcare Organizations Sep 30 Insilico Medicine Selects AI Designed Obesity Drug Candidate ISM1354 Sep 29 Truven launches MarketScan Snapshot for healthcare data checksLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
AbbVie Partners With Valkai on AI Tools for Clinical Development
ARPA-H Awards UpDoc Up to $9.2 Million for Clinical AI
Truven launches MarketScan Snapshot for healthcare data checks
MediSights Reports Study Using AI Agents for Myeloma Market Research
Authenticx Adds Form Automation and Routing to Safety AI
Daily AI Brief: the AI news that matters, in your inbox.